Cargando…

Impact of an Intervention to Control Imipenem-Resistant Acinetobacter baumannii and Its Resistance Mechanisms: An 8-Year Survey

BACKGROUND: This study aimed to examine the impact of an intervention carried out in 2011 to combat multi-drug resistance and outbreaks of imipenem-resistant Acinetobacter baumannii (IRAB), and to explore its resistance mechanism. METHODS: A total of 2572 isolates of A. baumannii, including 1673 IRA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lida, Tan, Pinghai, Zeng, Jianming, Yu, Xuegao, Cai, Yimei, Liao, Kang, Guo, Penghao, Chen, Yili, Wu, Zongwen, Qu, Pinghua, Cai, Renxin, Chen, Cha, Huang, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921317/ https://www.ncbi.nlm.nih.gov/pubmed/33664711 http://dx.doi.org/10.3389/fmicb.2020.610109

Ejemplares similares

Resistant mechanisms and molecular epidemiology of imipenem-resistant Acinetobacter baumannii
por: Xiao, Shu-Zhen, et al.
Publicado: (2016)

Mutation of CarO participates in drug resistance in imipenem‐resistant Acinetobacter baumannii
por: Zhu, Li‐Jing, et al.
Publicado: (2019)

Transcriptome profiling in imipenem-selected Acinetobacter baumannii
por: Chang, Kai-Chih, et al.
Publicado: (2014)

Ceftazidime/avibactam Improves the Antibacterial Efficacy of Polymyxin B Against Polymyxin B Heteroresistant KPC-2-Producing Klebsiella pneumoniae and Hinders Emergence of Resistant Subpopulation in vitro
por: Ma, Xingyan, et al.
Publicado: (2019)

Genetic Diversity of Imipenem-Resistant Acinetobacter baumannii Infections at an Intensive Care Unit
por: Alnimr, Amani, et al.
Publicado: (2020)

Dissemination of imipenem-resistant Acinetobacter baumannii with new plasmid-borne bla(OXA-72) in Taiwan
por: Kuo, Shu-Chen, et al.
Publicado: (2013)

The Impact of Inadequate Terminal Disinfection on an Outbreak of Imipenem-Resistant Acinetobacter baumannii in an Intensive Care Unit
por: Liu, Wei-Lun, et al.
Publicado: (2014)

Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU)
por: Alavi-Moghadam, Mostafa, et al.
Publicado: (2014)

Antimicrobial Resistance of Acinetobacter baumannii to Imipenem in Iran: A Systematic Review and Meta-Analysis
por: Pourhajibagher, Maryam, et al.
Publicado: (2016)

Antimicrobial Resistance Determinants in Imipenem-nonsusceptible Acinetobacter calcoaceticus-baumannii Complex Isolated in Daejeon, Korea
por: Sung, Ji Youn, et al.
Publicado: (2011)

Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical Isolates of Acinetobacter baumannii in Tehran
por: Abdi-Ali, Ahya, et al.
Publicado: (2014)

Correlation of Oxacillinase Gene Carriage With the Genetic Fingerprints of Imipenem-Resistant Clinical Isolates of Acinetobacter baumannii
por: Zanganeh, Zahra, et al.
Publicado: (2015)

Multidrug Resistant Acinetobacter baumannii: Risk Factors for Appearance of Imipenem Resistant Strains on Patients Formerly with Susceptible Strains
por: Ye, Jung-Jr, et al.
Publicado: (2010)

Molecular characterization of multidrug resistant strains of Acinetobacter baumannii isolated from pediatric intensive care unit in a Chinese tertiary hospital
por: Chen, Yili, et al.
Publicado: (2018)

In vitro synergistic effect of amlodipine and imipenem on the expression of the AdeABC efflux pump in multidrug-resistant Acinetobacter baumannii
por: Hu, Chao, et al.
Publicado: (2018)

A gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit in Guangdong, China
por: Ye, Dan, et al.
Publicado: (2015)

P068: Rapid detection of imipenem-resistant Acinetobacter baumannii for the surveillance culture using mass spectrometry
por: Kang, D-K, et al.
Publicado: (2013)

581. The Epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit and Carbapenem Use
por: Kim, Dongsub, et al.
Publicado: (2019)

The Changes in Epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit for 17 Years
por: Kim, Dongsub, et al.
Publicado: (2022)

Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
por: Dahdouh, E., et al.
Publicado: (2014)

Outbreaks of Imipenem Resistant Acinetobacter Baumannii Producing OXA-23 β-Lactamase in a Tertiary Care Hospital in Korea
por: Yang, Hee Young, et al.
Publicado: (2009)

Molecular analysis of imipenem-resistant Acinetobacter baumannii isolated from US service members wounded in Iraq, 2003–2008
por: HUANG, X.-Z., et al.
Publicado: (2012)

In vitro Comparison of Anti-Biofilm Effects against Carbapenem-Resistant Acinetobacter baumannii: Imipenem, Colistin, Tigecycline, Rifampicin and Combinations
por: Song, Joon Young, et al.
Publicado: (2015)

In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
por: Malekzadegan, Yalda, et al.
Publicado: (2019)

Role of Aders and OXA23 Genes among Imipenem Resistant Acinetobacter baumannii Isolates from Two Hospitals of Tehran, Iran
por: Ostad Asadolah-Malayeri, Helia, et al.
Publicado: (2016)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa
por: Xu, Ye, et al.
Publicado: (2020)

Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii
por: Kuo, Shu-Chen, et al.
Publicado: (2015)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection
por: Katip, Wasan, et al.
Publicado: (2022)

Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem
por: Chiu, Chun-Hsiang, et al.
Publicado: (2020)

715. Bulgecin A lowers Imipenem MICs in Clinical MDR Acinetobacter baumannii (ACB) Strains
por: Skalweit, Marion J, et al.
Publicado: (2019)

Multidrug-resistant Acinetobacter baumannii, Russia
por: Naas, Thierry, et al.
Publicado: (2007)

Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009)

Acinetobacter baumannii Antibiotic Resistance Mechanisms
por: Kyriakidis, Ioannis, et al.
Publicado: (2021)

Multidrug-Resistant Acinetobacter baumannii in Jordan
por: Al-Tamimi, Mohammad, et al.
Publicado: (2022)

Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023)

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases
por: Wareham, David W, et al.
Publicado: (2006)

Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii
por: Nucleo, Elisabetta, et al.
Publicado: (2009)

Overexpression of bla(OXA-58) Gene Driven by ISAba3 Is Associated with Imipenem Resistance in a Clinical Acinetobacter baumannii Isolate from Vietnam
por: Nguyen, Anh T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g43mhs50dt3cjvpkq03l9j114s